Abstract
The genetic polymorphisms in E-cadherin gene (CDH1) may affect invasive/metastatic development of gastric cancer by altering gene transcriptional activity of epithelial cell. Our study aims to explore the associations among CDH1 gene polymorphisms, and predisposition of gastric cancer. We genotyped four potentially functional polymorphisms (rs13689, rs1801552, rs16260 and rs17690554) of the CDH1 gene in a case–control study of 387 incident gastric cancer cases and 392 healthy controls by polymerase chain reaction-ligation detection reaction methods (PCR-LDR) and measured the plasma CDH1 levels using enzyme immunoassay among the subjects. The median and inter-quartile range were adopted for representing the mean level of non-normally distributed data, and we found the level of plasma CDH1 in gastric cancer patients (median: 171.00 pg/ml; inter-quartile range: 257.10 pg/ml) were significantly higher than that of controls (median: 137.40 pg/ml; inter-quartile range: 83.90 pg/ml, P = 0.003). However, none of the four polymorphisms or their haplotypes achieved significant differences in their distributions between gastric cancer cases and controls, and interestingly, in the subgroup analysis of gastric cancer, we found that CA genotype of rs26160 and CG genotype of rs17690554 were associated with the risk of diffuse gastric cancer, compared with their wild genotypes (OR = 2.98, 95 % CI: 1.60–5.53; OR = 2.10, 95 % CI: 1.14–3.85, respectively, P < 0.05). In conclusion, our results indicated that plasma CDH1 levels may serve as a risk marker against gastric cancer and variant genotypes of rs26160 and rs17690554 may contribute to the etiology of diffuse gastric cancer in this study. Further studies are warranted to verify these findings.
Similar content being viewed by others
References
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002, CA. Cancer J Clin 55:74–108
Sun X, Mu R, Zhou Y (2002) 1990–1992 mortality of stomach cancer in China. Zhonghua Zhong Liu Za Zhi 24:4–8
Kangelaris KN, Gruber SB (2007) Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer. JAMA 297:2410–2411
Berx G, Becker KF, Ho fler H, van Roy F (1998) Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12:226–237
Oliveira C, Seruca R, Caldas C (2003) Genetic screening for hereditary diffuse gastric cancer. Expert Rev Mol Diagn 3:201–215
Al-Moundhri MS, Al-Khanbashi M, Al-Kindi M, Al-Nabhani M, Burney IA, Al-Farsi A (2010) Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J Gastroenterol 16:3432–3436
Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, Wang X, Spitz MR, Wei Q (2000) Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 88:601–606
Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, Wang X, Spitz MR, Wei Q (2001) Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 95:332–336
Grunwald GB (1993) The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 5:797–805
Katoh M (2007) Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther 6:832–839
Amada H, Shinmura K, Ikeda S, Tao H, Otani T, Hanaoka T (2007) Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand J Gastroenterol 42:1479–1485
Li Y, Tang Y, Zhou R, Sun D, Duan Y, Wang N, Chen Z, Shen N (2011) Genetic polymorphism in the 3′-untranslated region of the E-cadherin gene is associated with risk of different cancers. Mol Carcinog 50:857–862
Wang Q, Gu D, Wang M, Zhang Z, Tang J, Chen J (2011) The E-cadherin (CDH1) −160C>A polymorphism associated with gastric cancer among Asians but not Europeans. DNA Cell Biol 30:395–400
Chen B, Zhou Y, Yang P, Liu L, Qin XP, Wu XT (2011) CDH1 −160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer. Cytokine 55:266–273
Acknowledgments
Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Natural Science Foundation (BK2008461); National Natural Science Foundation of China (30973715 and 81001502); Research Fund for the Doctoral Program of Higher Education of China (20103237110011).
Author information
Authors and Affiliations
Corresponding author
Additional information
Z. Zhan and J. Wu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhan, Z., Wu, J., Zhang, Jf. et al. CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population. Mol Biol Rep 39, 8107–8113 (2012). https://doi.org/10.1007/s11033-012-1658-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-1658-0